Firstly, our results showed that global levels of H3K9ac were substantially reduced following siRNA-mediated silencing of PCAF expression in cervical cancer cell lines, indicating that impaired PCAF function may impact the capacity to acetylate H3K9 in cervical cancer (Fig. 5i-j). The gene discussed is KAT2B; the disease is cervical carcinoma.